NO306380B1 - Vannulöselig bioforlikelig gel - Google Patents
Vannulöselig bioforlikelig gel Download PDFInfo
- Publication number
- NO306380B1 NO306380B1 NO924875A NO924875A NO306380B1 NO 306380 B1 NO306380 B1 NO 306380B1 NO 924875 A NO924875 A NO 924875A NO 924875 A NO924875 A NO 924875A NO 306380 B1 NO306380 B1 NO 306380B1
- Authority
- NO
- Norway
- Prior art keywords
- gel
- water
- mmol
- edc
- films
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 90
- 229920002674 hyaluronan Polymers 0.000 claims description 82
- 229960003160 hyaluronic acid Drugs 0.000 claims description 82
- 150000004676 glycans Chemical class 0.000 claims description 26
- 229920001282 polysaccharide Polymers 0.000 claims description 26
- 239000005017 polysaccharide Substances 0.000 claims description 26
- 239000011541 reaction mixture Substances 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 19
- -1 carboxymethylamylose Polymers 0.000 claims description 11
- 239000012528 membrane Substances 0.000 claims description 11
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 10
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 9
- 230000003213 activating effect Effects 0.000 claims description 9
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 9
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 9
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 150000001718 carbodiimides Chemical class 0.000 claims description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 2
- 229920002971 Heparan sulfate Polymers 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 229940019765 dermatin Drugs 0.000 claims description 2
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- 229960002897 heparin Drugs 0.000 claims description 2
- 239000010408 film Substances 0.000 description 64
- 239000000499 gel Substances 0.000 description 48
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 239000012190 activator Substances 0.000 description 18
- 239000003153 chemical reaction reagent Substances 0.000 description 13
- 239000000463 material Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 9
- 229920002385 Sodium hyaluronate Polymers 0.000 description 8
- QVDXUKJJGUSGLS-LURJTMIESA-N methyl L-leucinate Chemical compound COC(=O)[C@@H](N)CC(C)C QVDXUKJJGUSGLS-LURJTMIESA-N 0.000 description 8
- 229940010747 sodium hyaluronate Drugs 0.000 description 8
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 6
- 239000004472 Lysine Substances 0.000 description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000000017 hydrogel Substances 0.000 description 5
- KPNBUPJZFJCCIQ-LURJTMIESA-N methyl L-lysinate Chemical compound COC(=O)[C@@H](N)CCCCN KPNBUPJZFJCCIQ-LURJTMIESA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- 229920002683 Glycosaminoglycan Polymers 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000013270 controlled release Methods 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- DODCBMODXGJOKD-RGMNGODLSA-N methyl (2s)-2-amino-4-methylpentanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CC(C)C DODCBMODXGJOKD-RGMNGODLSA-N 0.000 description 4
- 239000012038 nucleophile Substances 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 206010060932 Postoperative adhesion Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- NOUDPBCEONUCOV-FJXQXJEOSA-N [(2s)-1-ethoxy-4-methyl-1-oxopentan-2-yl]azanium;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)CC(C)C NOUDPBCEONUCOV-FJXQXJEOSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000005266 casting Methods 0.000 description 3
- 210000004534 cecum Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229940014041 hyaluronate Drugs 0.000 description 3
- 229960003136 leucine Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- UKAMWVYNAVUZEA-UHFFFAOYSA-N 2-butylnaphthalene Chemical compound C1=CC=CC2=CC(CCCC)=CC=C21 UKAMWVYNAVUZEA-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000003862 amino acid derivatives Chemical class 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- KUGLDBMQKZTXPW-JEDNCBNOSA-N methyl (2s)-2-amino-3-methylbutanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)C(C)C KUGLDBMQKZTXPW-JEDNCBNOSA-N 0.000 description 2
- HQEIPVHJHZTMDP-JEDNCBNOSA-N methyl (2s)-pyrrolidine-2-carboxylate;hydrochloride Chemical compound Cl.COC(=O)[C@@H]1CCCN1 HQEIPVHJHZTMDP-JEDNCBNOSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- MWPNPNLDBXDQCC-UHFFFAOYSA-N 2-amino-3-(diethylamino)propanoic acid Chemical compound CCN(CC)CC(N)C(O)=O MWPNPNLDBXDQCC-UHFFFAOYSA-N 0.000 description 1
- AGSKWMRPXWHSPF-UHFFFAOYSA-M 3-(ethyliminomethylideneamino)propyl-trimethylazanium;iodide Chemical compound [I-].CCN=C=NCCC[N+](C)(C)C AGSKWMRPXWHSPF-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010012186 Delayed delivery Diseases 0.000 description 1
- ZFIVKAOQEXOYFY-UHFFFAOYSA-N Diepoxybutane Chemical compound C1OC1C1OC1 ZFIVKAOQEXOYFY-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- FORGMRSGVSYZQR-YFKPBYRVSA-N L-leucinamide Chemical compound CC(C)C[C@H](N)C(N)=O FORGMRSGVSYZQR-YFKPBYRVSA-N 0.000 description 1
- NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 description 1
- WBSCNDJQPKSPII-KKUMJFAQSA-N Lys-Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O WBSCNDJQPKSPII-KKUMJFAQSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical group O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical group ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- WVJOGYWFVNTSAU-UHFFFAOYSA-N dimethylol ethylene urea Chemical compound OCN1CCN(CO)C1=O WVJOGYWFVNTSAU-UHFFFAOYSA-N 0.000 description 1
- 125000002228 disulfide group Chemical group 0.000 description 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000012844 infrared spectroscopy analysis Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- VEEIFXWJNCAVEQ-RGMNGODLSA-N methyl (2s)-2-amino-3-(1h-imidazol-5-yl)propanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CC1=CNC=N1 VEEIFXWJNCAVEQ-RGMNGODLSA-N 0.000 description 1
- SWVMLNPDTIFDDY-FVGYRXGTSA-N methyl (2s)-2-amino-3-phenylpropanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CC1=CC=CC=C1 SWVMLNPDTIFDDY-FVGYRXGTSA-N 0.000 description 1
- XKVHMRBXIJTLBM-JEDNCBNOSA-N methyl (2s)-2-amino-5-(diaminomethylideneamino)pentanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CCCN=C(N)N XKVHMRBXIJTLBM-JEDNCBNOSA-N 0.000 description 1
- KQSSATDQUYCRGS-UHFFFAOYSA-N methyl glycinate Chemical compound COC(=O)CN KQSSATDQUYCRGS-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- QUBQYFYWUJJAAK-UHFFFAOYSA-N oxymethurea Chemical compound OCNC(=O)NCO QUBQYFYWUJJAAK-UHFFFAOYSA-N 0.000 description 1
- 229950005308 oxymethurea Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001228 polyisocyanate Polymers 0.000 description 1
- 239000005056 polyisocyanate Substances 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- RFUWRXIYTQGFGA-QRPNPIFTSA-N tert-butyl (2s)-2-amino-4-methylpentanoate;hydron;chloride Chemical compound Cl.CC(C)C[C@H](N)C(=O)OC(C)(C)C RFUWRXIYTQGFGA-QRPNPIFTSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000004520 water soluble gel Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/041—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/543,163 US5017229A (en) | 1990-06-25 | 1990-06-25 | Water insoluble derivatives of hyaluronic acid |
| PCT/US1991/004543 WO1992000105A1 (fr) | 1990-06-25 | 1991-06-25 | Derives d'acide hyaluronique insolubles dans l'eau |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO924875D0 NO924875D0 (no) | 1992-12-16 |
| NO924875L NO924875L (no) | 1992-12-16 |
| NO306380B1 true NO306380B1 (no) | 1999-11-01 |
Family
ID=24166845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO924875A NO306380B1 (no) | 1990-06-25 | 1992-12-16 | Vannulöselig bioforlikelig gel |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5017229A (fr) |
| EP (1) | EP0537292B1 (fr) |
| JP (1) | JP3399526B2 (fr) |
| AT (1) | ATE151294T1 (fr) |
| AU (1) | AU660282B2 (fr) |
| DE (1) | DE69125609T2 (fr) |
| DK (1) | DK0537292T3 (fr) |
| ES (1) | ES2100954T3 (fr) |
| FI (1) | FI103381B (fr) |
| GR (1) | GR3023436T3 (fr) |
| NO (1) | NO306380B1 (fr) |
| WO (1) | WO1992000105A1 (fr) |
Families Citing this family (213)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6610669B1 (en) * | 1987-09-18 | 2003-08-26 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
| US6235726B1 (en) * | 1987-09-18 | 2001-05-22 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
| US6030958A (en) * | 1987-09-18 | 2000-02-29 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
| US6174999B1 (en) * | 1987-09-18 | 2001-01-16 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
| US5527893A (en) * | 1987-09-18 | 1996-06-18 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
| IT1219587B (it) * | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
| US5510418A (en) * | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
| US5356883A (en) | 1989-08-01 | 1994-10-18 | Research Foundation Of State University Of N.Y. | Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use |
| US5234914A (en) * | 1991-06-11 | 1993-08-10 | Patent Biopharmaceutics, Inc. | Methods of treating hemorrhoids and anorecial disease |
| AU636544B1 (en) * | 1991-11-27 | 1993-04-29 | Lignyte Co., Ltd. | Water insoluble biocompatible hyaluronic acid polyion complex and method of making the same |
| CA2072918A1 (fr) * | 1992-02-14 | 1993-08-15 | Jian Qin | Polysaccharides modifiees ayant un pouvoir absorbant ameliore et methode de preparation de ces polysaccharides |
| JP2995090B2 (ja) * | 1993-03-19 | 1999-12-27 | キユー・メド・アクチエボラーグ | 組織増大のための組成物および方法 |
| US5616568A (en) * | 1993-11-30 | 1997-04-01 | The Research Foundation Of State University Of New York | Functionalized derivatives of hyaluronic acid |
| ITPD940054A1 (it) * | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
| US5585361A (en) | 1994-06-07 | 1996-12-17 | Genzyme Corporation | Methods for the inhibition of platelet adherence and aggregation |
| US5931165A (en) * | 1994-09-06 | 1999-08-03 | Fusion Medical Technologies, Inc. | Films having improved characteristics and methods for their preparation and use |
| US6294202B1 (en) | 1994-10-06 | 2001-09-25 | Genzyme Corporation | Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers |
| US6063396A (en) * | 1994-10-26 | 2000-05-16 | Houston Biotechnology Incorporated | Methods and compositions for the modulation of cell proliferation and wound healing |
| US6063116A (en) * | 1994-10-26 | 2000-05-16 | Medarex, Inc. | Modulation of cell proliferation and wound healing |
| US5498705A (en) * | 1995-02-22 | 1996-03-12 | Kimberly-Clark Corporation | Modified polysaccharides having improved absorbent properties and process for the preparation thereof |
| US6262255B1 (en) * | 1995-04-05 | 2001-07-17 | Biomm, Inc. | Non-immunogenic, biocompatible macromolecular membrane compositions, and methods for making them |
| US5827937A (en) * | 1995-07-17 | 1998-10-27 | Q Med Ab | Polysaccharide gel composition |
| US6036977A (en) * | 1995-09-29 | 2000-03-14 | L.A.M. Pharmaceutical Corp. | Drug preparations for treating sexual dysfunction |
| US5952006A (en) * | 1995-09-29 | 1999-09-14 | L.A.M. Pharmaceuticals, Llc | Drug preparations for treating impotency |
| US6251436B1 (en) | 1995-09-29 | 2001-06-26 | L.A.M. Pharmaceutical Corporation | Drug preparations for treating sexual dysfunction |
| US5897880A (en) * | 1995-09-29 | 1999-04-27 | Lam Pharmaceuticals, Llc. | Topical drug preparations |
| US5716631A (en) * | 1995-09-29 | 1998-02-10 | Rdn Therapeutics Inc. | Long acting narcotic analgesics and antagonists |
| US6387407B1 (en) | 1995-09-29 | 2002-05-14 | L.A.M. Pharmaceutical Corporation | Topical drug preparations |
| EP2111876B1 (fr) * | 1995-12-18 | 2011-09-07 | AngioDevice International GmbH | Compositions de polymère réticulé et leurs procédés d'utilisation |
| US6833408B2 (en) * | 1995-12-18 | 2004-12-21 | Cohesion Technologies, Inc. | Methods for tissue repair using adhesive materials |
| US7883693B2 (en) | 1995-12-18 | 2011-02-08 | Angiodevice International Gmbh | Compositions and systems for forming crosslinked biomaterials and methods of preparation of use |
| US5791352A (en) * | 1996-06-19 | 1998-08-11 | Fusion Medical Technologies, Inc. | Methods and compositions for inhibiting tissue adhesion |
| US6063061A (en) * | 1996-08-27 | 2000-05-16 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US7435425B2 (en) * | 2001-07-17 | 2008-10-14 | Baxter International, Inc. | Dry hemostatic compositions and methods for their preparation |
| US8603511B2 (en) | 1996-08-27 | 2013-12-10 | Baxter International, Inc. | Fragmented polymeric compositions and methods for their use |
| US6066325A (en) * | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US8303981B2 (en) | 1996-08-27 | 2012-11-06 | Baxter International Inc. | Fragmented polymeric compositions and methods for their use |
| US7871637B2 (en) | 1996-08-27 | 2011-01-18 | Baxter International Inc. | Dry hemostatic compositions and methods for their preparation |
| FR2752843B1 (fr) * | 1996-08-30 | 1998-10-16 | Sod Conseils Rech Applic | Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique |
| US6566406B1 (en) | 1998-12-04 | 2003-05-20 | Incept, Llc | Biocompatible crosslinked polymers |
| US8003705B2 (en) | 1996-09-23 | 2011-08-23 | Incept Llc | Biocompatible hydrogels made with small molecule precursors |
| DE19712708A1 (de) * | 1997-03-26 | 1998-10-01 | Thueringisches Inst Textil | Getrocknete kontaminationsarme Hydrokolloide und Hydrogele |
| US7192984B2 (en) * | 1997-06-17 | 2007-03-20 | Fziomed, Inc. | Compositions of polyacids and polyethers and methods for their use as dermal fillers |
| US6869938B1 (en) | 1997-06-17 | 2005-03-22 | Fziomed, Inc. | Compositions of polyacids and polyethers and methods for their use in reducing adhesions |
| US20050074495A1 (en) * | 1997-06-17 | 2005-04-07 | Fziomed, Inc. | Compositions of polyacids and methods for their use in reducing adhesions |
| US20040096422A1 (en) * | 1997-06-17 | 2004-05-20 | Schwartz Herbert E. | Compositions of polyacids and polyethers and methods for their use in reducing pain |
| US5906997A (en) * | 1997-06-17 | 1999-05-25 | Fzio Med, Inc. | Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions |
| US6229009B1 (en) | 1997-08-29 | 2001-05-08 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Polycarboxylic based cross-linked copolymers |
| US6919076B1 (en) | 1998-01-20 | 2005-07-19 | Pericor Science, Inc. | Conjugates of agents and transglutaminase substrate linking molecules |
| US6958148B1 (en) | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
| US6630457B1 (en) | 1998-09-18 | 2003-10-07 | Orthogene Llc | Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
| FR2790391B1 (fr) | 1999-03-02 | 2002-11-15 | Flamel Tech Sa | Moyen pour la prevention des adherences post-chirurgicales,a base de peptides collagenique reticule |
| JP2002539157A (ja) * | 1999-03-15 | 2002-11-19 | トラスティーズ オブ ボストン ユニバーシティ | 血管新生阻害 |
| US20040048021A1 (en) * | 1999-03-19 | 2004-03-11 | Wan Barbara Y. F. | Surface modification of substrates |
| WO2000059490A2 (fr) * | 1999-04-06 | 2000-10-12 | Genzyme Corporation | Compositions immunomodulatrices et procedes d'utilisation |
| FR2799196B1 (fr) * | 1999-10-04 | 2002-02-08 | Sod Conseils Rech Applic | Copolymeres reticules a base de copolymeres polycarboxyliques non reticules |
| US7651703B2 (en) | 1999-10-15 | 2010-01-26 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
| US7582311B1 (en) | 1999-10-15 | 2009-09-01 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
| KR20020062301A (ko) * | 1999-11-09 | 2002-07-25 | 덴끼 가가꾸 고교 가부시키가이샤 | 수난용성화된 가용성 셀룰로오스 유도체의 용도 및 그제조방법 |
| US20030211166A1 (en) * | 2001-07-31 | 2003-11-13 | Yamamoto Ronald K | Microparticulate biomaterial composition for medical use |
| DE60016455T2 (de) | 1999-12-17 | 2005-12-15 | Genzyme Corp., Cambridge | Chirurgische prothese |
| AU1894901A (en) * | 1999-12-21 | 2001-07-03 | Ajinomoto Co., Inc. | Partial ester of cellulose with nitrogenous carboxylic acid and process for producing the same |
| US6566345B2 (en) | 2000-04-28 | 2003-05-20 | Fziomed, Inc. | Polyacid/polyalkylene oxide foams and gels and methods for their delivery |
| WO2001056475A1 (fr) * | 2000-02-03 | 2001-08-09 | Tissuemed Limited | Dispositif permettant de fermer une perforation chirurgicale |
| US6521223B1 (en) * | 2000-02-14 | 2003-02-18 | Genzyme Corporation | Single phase gels for the prevention of adhesions |
| US6749865B2 (en) * | 2000-02-15 | 2004-06-15 | Genzyme Corporation | Modification of biopolymers for improved drug delivery |
| WO2001082863A2 (fr) * | 2000-04-28 | 2001-11-08 | Fziomed, Inc. | Gels et mousses d'oxyde polyacide/polyalkylene et procedes d'apport de ceux-ci |
| WO2002009789A2 (fr) * | 2000-08-02 | 2002-02-07 | Aesculap Ag & Co. Kg | Produit technique medical, son procede de production et de preparation pour la chirurgie |
| AU2001286701A1 (en) * | 2000-08-31 | 2002-03-13 | Genzyme Biosurgery Corporation | Hyaluronan-based antiadhesion compositions, their preparation and use |
| KR100375299B1 (ko) | 2000-10-10 | 2003-03-10 | 주식회사 엘지생명과학 | 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법 |
| ATE286408T1 (de) * | 2000-10-23 | 2005-01-15 | Tissuemed Ltd | Selbstklebende, hydratierbare matrix für therapeutische anwendungen |
| US6710162B2 (en) * | 2001-02-16 | 2004-03-23 | Genzyme Corporation | Method of drying a material having a cohesive phase |
| ATE312076T1 (de) * | 2001-02-22 | 2005-12-15 | Anika Therapeutics Inc | Thiol-modifizierte hyaluronan-derivate |
| US20020172712A1 (en) * | 2001-03-19 | 2002-11-21 | Alan Drizen | Antiemetic, anti-motion sustained release drug delivery system |
| US20030138494A1 (en) * | 2001-05-15 | 2003-07-24 | L.A.M. Pharmaceutical Corporation | Drug preparations for treating sexual dysfunction |
| US20030187381A1 (en) * | 2001-12-28 | 2003-10-02 | Genzyme Corporation | Bioresorbable foam packing device and use thereof |
| EP1507543A4 (fr) * | 2002-05-09 | 2006-07-26 | Cambridgemed Inc | Composition pharmaceutique destinee au traitement de plaies et contenant du plasma ou du serum sanguins |
| US7299805B2 (en) * | 2002-06-07 | 2007-11-27 | Marctec, Llc | Scaffold and method for implanting cells |
| CN103638040A (zh) * | 2002-07-03 | 2014-03-19 | 派瑞克科学公司 | 透明质酸组合物以及使用方法 |
| AU2003264498A1 (en) * | 2002-09-18 | 2004-04-08 | Wakamoto Pharmaceutical Co., Ltd. | Transparent and reversibly heat-gelling aqueous compositions |
| US7862831B2 (en) * | 2002-10-09 | 2011-01-04 | Synthasome, Inc. | Method and material for enhanced tissue-biomaterial integration |
| US8673333B2 (en) * | 2002-09-25 | 2014-03-18 | The Johns Hopkins University | Cross-linked polymer matrices, and methods of making and using same |
| US20050069572A1 (en) * | 2002-10-09 | 2005-03-31 | Jennifer Elisseeff | Multi-layered polymerizing hydrogels for tissue regeneration |
| TWI251596B (en) * | 2002-12-31 | 2006-03-21 | Ind Tech Res Inst | Method for producing a double-crosslinked hyaluronate material |
| AU2003303678A1 (en) | 2003-01-03 | 2004-08-10 | Genzyme Corporation | Urea derivatives and their use as anti-inflammatory agents |
| US8138265B2 (en) * | 2003-01-10 | 2012-03-20 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| US7465766B2 (en) * | 2004-01-08 | 2008-12-16 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| US6982298B2 (en) * | 2003-01-10 | 2006-01-03 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| US8137688B2 (en) * | 2003-01-10 | 2012-03-20 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| KR20060003872A (ko) * | 2003-04-04 | 2006-01-11 | 티슈메드 리미티드 | 조직-부착성 제형물 |
| FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
| US8834864B2 (en) * | 2003-06-05 | 2014-09-16 | Baxter International Inc. | Methods for repairing and regenerating human dura mater |
| EP1640026A4 (fr) * | 2003-06-30 | 2011-12-07 | Denki Kagaku Kogyo Kk | Materiau inhibant l'adhesion dans une intervention sur les vertebres/le rachis |
| US7927626B2 (en) * | 2003-08-07 | 2011-04-19 | Ethicon, Inc. | Process of making flowable hemostatic compositions and devices containing such compositions |
| AU2004263149B2 (en) | 2003-08-07 | 2010-08-19 | Allergan, Inc. | Compositions for delivery of therapeutics into the eyes and methods for making and using same |
| US7625581B2 (en) * | 2003-12-19 | 2009-12-01 | Ethicon, Inc. | Tissue scaffolds for use in muscoloskeletal repairs |
| US7091191B2 (en) * | 2003-12-19 | 2006-08-15 | Ethicon, Inc. | Modified hyaluronic acid for use in musculoskeletal tissue repair |
| JP2005261608A (ja) * | 2004-03-18 | 2005-09-29 | Masato Kusunoki | 薬物を担持した生体吸収性ゲル、パウダーおよびフィルム |
| EP1744796B1 (fr) * | 2004-04-20 | 2015-03-18 | Genzyme Corporation | Implant chirurgical a mailles |
| US8067031B2 (en) | 2004-04-28 | 2011-11-29 | Angiodevice International Gmbh | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| EP1595528A1 (fr) * | 2004-05-14 | 2005-11-16 | Fibona Health Products GmbH | Composite Hyaferm |
| BRPI0514106A (pt) * | 2004-08-03 | 2008-05-27 | Tissuemed Ltd | materiais adesivos a tecidos |
| US7858107B2 (en) * | 2004-09-10 | 2010-12-28 | Medtronic Xomed, Inc. | Flexible bioresorbable hemostatic packing and stent having a preselectable in-vivo residence time |
| EP1796602A4 (fr) | 2004-09-17 | 2016-10-19 | Angiotech Pharm Inc | Composes multifonctionels pour la formation de biomateriaux reticules et leurs procedes de preparation et d'utilisation |
| US20060069063A1 (en) * | 2004-09-27 | 2006-03-30 | Yng-Jiin Wang | Crosslinked polygalacturonic acid used for postsurgical tissue adhesion prevention |
| EP1804717A4 (fr) | 2004-09-28 | 2015-11-18 | Atrium Medical Corp | Revetement d'administration de medicament pouvant etre utilise avec une endoprothese vasculaire |
| US8312836B2 (en) * | 2004-09-28 | 2012-11-20 | Atrium Medical Corporation | Method and apparatus for application of a fresh coating on a medical device |
| US8367099B2 (en) | 2004-09-28 | 2013-02-05 | Atrium Medical Corporation | Perforated fatty acid films |
| US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
| US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US9012506B2 (en) * | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US20060067976A1 (en) * | 2004-09-28 | 2006-03-30 | Atrium Medical Corporation | Formation of barrier layer |
| PT1817347T (pt) | 2004-11-24 | 2017-07-21 | Albumedix As | Resumo |
| CN1325125C (zh) * | 2004-12-23 | 2007-07-11 | 中国人民解放军第二军医大学 | 一种防粘连生物膜 |
| ITTO20040918A1 (it) * | 2004-12-29 | 2005-03-29 | Luigi Ambrosio | Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione |
| WO2006089119A2 (fr) * | 2005-02-18 | 2006-08-24 | Cartilix, Inc. | Adhesif biologique |
| DK1911769T3 (da) | 2005-08-04 | 2014-01-13 | Teijin Ltd | Cellulosederivat |
| US7323184B2 (en) * | 2005-08-22 | 2008-01-29 | Healagenics, Inc. | Compositions and methods for the treatment of wounds and the reduction of scar formation |
| US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
| US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
| CA2626030A1 (fr) | 2005-10-15 | 2007-04-26 | Atrium Medical Corporation | Gels hydrophobes reticules pour revetements bioabsorbables de vecteur de medicament |
| US20070110788A1 (en) * | 2005-11-14 | 2007-05-17 | Hissong James B | Injectable formulation capable of forming a drug-releasing device |
| WO2007088402A2 (fr) | 2006-02-03 | 2007-08-09 | Tissuemed Limited | Materiaux d'adhérence tissulaire |
| US20090018575A1 (en) * | 2006-03-01 | 2009-01-15 | Tissuemed Limited | Tissue-adhesive formulations |
| WO2007108775A1 (fr) * | 2006-03-21 | 2007-09-27 | Agency For Science, Technology And Research | Matériau pour polyélectrolyte à adhésion cellulaire pour emploi en tant que membrane et revêtement |
| JP2009533455A (ja) * | 2006-04-12 | 2009-09-17 | マサチューセッツ インスティテュート オブ テクノロジー | 癒着を阻害するための組成物および方法 |
| US20070264296A1 (en) * | 2006-05-10 | 2007-11-15 | Myntti Matthew F | Biofilm extracellular polysachharide solvating system |
| US7976873B2 (en) * | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
| US7959943B2 (en) * | 2006-05-10 | 2011-06-14 | Medtronics Xomed, Inc. | Solvating system and sealant for medical use in the middle or inner ear |
| US7993675B2 (en) | 2006-05-10 | 2011-08-09 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use in the sinuses and nasal passages |
| EP2021045B1 (fr) * | 2006-05-31 | 2016-03-16 | Baxter International Inc. | Collagène pour utilisation dans la prévention de formation de fibrose après chirurgie rachidienne |
| US8313762B2 (en) | 2006-07-05 | 2012-11-20 | Medtronic Xomed, Inc. | Flexible bioresorbable hemostatic packing and stent |
| TWI436793B (zh) | 2006-08-02 | 2014-05-11 | Baxter Int | 快速作用之乾密封膠及其使用和製造方法 |
| ITMI20061726A1 (it) * | 2006-09-11 | 2008-03-12 | Fidia Farmaceutici | Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry |
| WO2008057344A2 (fr) | 2006-11-06 | 2008-05-15 | Atrium Medical Corporation | Filet chirurgical enrobe |
| US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
| US8114159B2 (en) * | 2006-11-20 | 2012-02-14 | Depuy Spine, Inc. | Anterior spinal vessel protector |
| AU2008213323B2 (en) | 2007-02-06 | 2012-05-24 | Teijin Limited | Cellulose derivative and method for production thereof |
| JP5242921B2 (ja) * | 2007-02-06 | 2013-07-24 | 帝人株式会社 | ホスファチジルエタノールアミン結合多糖類の製造方法 |
| US8088095B2 (en) * | 2007-02-08 | 2012-01-03 | Medtronic Xomed, Inc. | Polymeric sealant for medical use |
| US8658148B2 (en) | 2007-06-22 | 2014-02-25 | Genzyme Corporation | Chemically modified dendrimers |
| GB0715514D0 (en) * | 2007-08-10 | 2007-09-19 | Tissuemed Ltd | Coated medical devices |
| AU2008317874B2 (en) | 2007-10-30 | 2013-12-19 | Baxter Healthcare S.A. | Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects |
| BRPI0819075A2 (pt) | 2007-11-16 | 2014-10-07 | Vicept Therapeutics Inc | Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico |
| US9345809B2 (en) * | 2007-11-28 | 2016-05-24 | Fziomed, Inc. | Carboxymethylcellulose polyethylene glycol compositions for medical uses |
| US8394782B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
| US9109051B2 (en) * | 2007-12-19 | 2015-08-18 | Evonik Goldschmidt Gmbh | Crosslinked hyaluronic acid in emulsion |
| US8080260B2 (en) | 2008-02-13 | 2011-12-20 | The Cleveland Clinic Foundation | Molecular enhancement of extracellular matrix and methods of use |
| US8668863B2 (en) | 2008-02-26 | 2014-03-11 | Board Of Regents, The University Of Texas System | Dendritic macroporous hydrogels prepared by crystal templating |
| US8642831B2 (en) | 2008-02-29 | 2014-02-04 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
| US7842714B2 (en) * | 2008-03-03 | 2010-11-30 | Allergan, Inc. | Ketorolac tromethamine compositions for treating ocular pain |
| US9192571B2 (en) * | 2008-03-03 | 2015-11-24 | Allergan, Inc. | Ketorolac tromethamine compositions for treating or preventing ocular pain |
| US8410180B2 (en) * | 2008-04-30 | 2013-04-02 | The Cleveland Clinic Foundation | Methods to treat urinary incontinence |
| US8932622B2 (en) * | 2008-06-03 | 2015-01-13 | Actamax Surgical Materials, Llc | Tissue coating for preventing undesired tissue-to-tissue adhesions |
| CA2727432C (fr) | 2008-06-12 | 2016-10-11 | Medtronic Xomed, Inc. | Methode de traitement de plaies chroniques a l'aide d'un systeme de solvant de substance polymere extracellulaire |
| US8357795B2 (en) | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
| JP5469065B2 (ja) * | 2008-08-05 | 2014-04-09 | 帝人株式会社 | ハイドロゲル |
| AU2009288118B2 (en) | 2008-09-02 | 2014-12-11 | Allergan, Inc. | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
| WO2010042427A2 (fr) | 2008-10-06 | 2010-04-15 | Microbial Defense Systems, Llc | Composition antimicrobienne et ses procédés de fabrication et d'utilisation |
| US9039783B2 (en) | 2009-05-18 | 2015-05-26 | Baxter International, Inc. | Method for the improvement of mesh implant biocompatibility |
| EP2442835B1 (fr) * | 2009-06-16 | 2014-12-10 | Baxter International Inc | Éponge hémostatique |
| US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
| MX2012007056A (es) | 2009-12-16 | 2012-09-28 | Baxter Healthcare Sa | Esponja hemostatica. |
| WO2011081162A1 (fr) | 2009-12-28 | 2011-07-07 | 川澄化学工業株式会社 | Matériau antiadhésif |
| US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
| US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
| WO2011110894A2 (fr) | 2010-03-12 | 2011-09-15 | Allergan Industrie Sas | Composition fluide pour l'amélioration d'états cutanés |
| PL3078388T3 (pl) | 2010-03-22 | 2019-08-30 | Allergan, Inc. | Usieciowane hydrożele do powiększania tkanek miękkich |
| SA111320355B1 (ar) | 2010-04-07 | 2015-01-08 | Baxter Heathcare S A | إسفنجة لايقاف النزف |
| JP6289096B2 (ja) | 2010-06-01 | 2018-03-07 | バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ | 乾燥した安定な止血組成物を作製するためのプロセス |
| KR101814841B1 (ko) | 2010-06-01 | 2018-01-03 | 백스터 인터내셔널 인코포레이티드 | 건조 및 안정한 지혈 조성물의 제조 방법 |
| EP2575770B1 (fr) | 2010-06-01 | 2017-03-22 | Baxter International Inc | Procédé de fabrication de compositions hémostatiques sous forme sèche et stable |
| WO2012009707A2 (fr) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition et procédés destinés à modifier la vitesse d'hydrolyse de substances vulcanisées à base d'huile |
| US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
| US8946194B2 (en) | 2010-10-08 | 2015-02-03 | Board Of Regents, University Of Texas System | One-step processing of hydrogels for mechanically robust and chemically desired features |
| JP6042815B2 (ja) | 2010-10-08 | 2016-12-14 | ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム | 生物医学的応用のためのアルギン酸塩及びヒアルロン酸を用いる抗癒着性バリア膜 |
| JP6463629B2 (ja) | 2011-05-10 | 2019-02-06 | ネクスト サイエンス アイピー ホールディングス ピーティワイ エルティーディ | 抗菌性固体およびその製造方法 |
| US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
| US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
| KR102015676B1 (ko) | 2011-06-03 | 2019-10-21 | 알러간, 인코포레이티드 | 항산화제를 포함하는 피부 충전제 조성물 |
| ES2899992T3 (es) | 2011-08-10 | 2022-03-15 | Glycores 2000 Srl | Acido hialurónico reticulado de bajo peso molecular resistente a la degradación |
| US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
| US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
| KR102102002B1 (ko) | 2011-10-11 | 2020-04-20 | 백스터 인터내셔널 인코포레이티드 | 지혈 조성물 |
| MX346958B (es) | 2011-10-11 | 2017-04-06 | Baxter Int | Composición hemostatica. |
| WO2013060770A1 (fr) | 2011-10-27 | 2013-05-02 | Baxter International Inc. | Compositions hémostatiques |
| CN104159527B (zh) | 2012-03-06 | 2017-04-12 | 弗罗桑医疗设备公司 | 包含止血糊剂的压力容器 |
| FR2988585B1 (fr) | 2012-03-28 | 2015-04-03 | Cousin Biotech | Plaque viscerale destinee a la coelioscopie |
| CN104349797B (zh) | 2012-06-12 | 2017-10-27 | 弗罗桑医疗设备公司 | 干止血组合物 |
| US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
| EP4253454A3 (fr) | 2012-12-11 | 2024-01-03 | Board of Regents, The University of Texas System | Membrane à hydrogel pour la prévention de l'adhérence |
| US11565027B2 (en) | 2012-12-11 | 2023-01-31 | Board Of Regents, The University Of Texas System | Hydrogel membrane for adhesion prevention |
| PL2950783T3 (pl) | 2013-02-01 | 2019-11-29 | Allergan Inc | Sztuczne łzy zawierające hialuronian sodu oraz karboksymetylocelulozę |
| US20140315828A1 (en) | 2013-04-22 | 2014-10-23 | Allergan, Inc. | Cross-linked silk-hyaluronic acid compositions |
| CA2912357C (fr) | 2013-06-21 | 2019-12-31 | Ferrosan Medical Devices A/S | Composition seche dilatee sous vide, et seringue pour la retenir |
| JP6489485B2 (ja) | 2013-12-11 | 2019-03-27 | フェロサン メディカル デバイシーズ エイ／エス | 押し出し増強因子を含んでいる乾燥組成物 |
| WO2016051219A1 (fr) | 2014-09-30 | 2016-04-07 | Allergan Industrie, Sas | Compositions d'hydrogel stables pourvues d'additifs |
| CN106999621B (zh) | 2014-10-13 | 2020-07-03 | 弗罗桑医疗设备公司 | 用于止血和伤口愈合的干组合物 |
| BR112017013565B1 (pt) | 2014-12-24 | 2021-12-28 | Ferrosan Medical Devices A/S | Seringa para retenção e mistura de primeira e segunda substâncias |
| WO2016128783A1 (fr) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions et méthodes pour améliorer l'apparence de la peau |
| CN107771093B (zh) | 2015-07-03 | 2021-06-15 | 弗罗桑医疗设备公司 | 用于混合两种组分和用于在存储条件下保持真空的注射器 |
| CN105381501A (zh) * | 2015-12-15 | 2016-03-09 | 日照天一生物医疗科技有限公司 | 可降解生物复合止血膜及其制备方法 |
| CA3033536A1 (fr) | 2016-08-24 | 2018-03-01 | Allergan, Inc. | Hydrogels co-reticules d'acide hyaluronique-fibroine pour ameliorer la viabilite des greffes tissulaires et pour l'augmentation des tissus mous |
| WO2018165327A1 (fr) | 2017-03-08 | 2018-09-13 | Alafair Biosciences, Inc. | Milieu hydrogel pour le stockage et la conservation de tissu |
| JP7395113B2 (ja) | 2018-05-09 | 2023-12-11 | フェロサン メディカル デバイシーズ エイ／エス | 止血組成物を調製する方法 |
| JP7396804B2 (ja) * | 2019-03-01 | 2023-12-12 | 大日本印刷株式会社 | ゲル膜の製造方法およびゲル膜 |
| JP7311983B2 (ja) * | 2019-03-01 | 2023-07-20 | 大日本印刷株式会社 | ゲル膜の製造方法およびゲル膜 |
| RU2744752C1 (ru) * | 2020-08-28 | 2021-03-15 | Федеральное государственное бюджетное учреждение науки Институт проблем химико-энергетических технологий Сибирского отделения Российской академии наук (ИПХЭТ СО РАН) | Способ получения противоспаечного материала |
| CN117915933A (zh) | 2021-09-01 | 2024-04-19 | 上海其胜生物制剂有限公司 | 使用含有软骨细胞或干细胞的可注射可原位聚合胶原组合物进行软骨再生 |
| WO2023056433A1 (fr) * | 2021-10-01 | 2023-04-06 | Northwestern University | Suspension épaisse composite supramoléculaire-covalente pour la réparation de cartilage |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1238043A (fr) * | 1983-12-15 | 1988-06-14 | Endre A. Balazs | Preparations d'acide hyaluronique insolubles dans l'eau et procede de production |
| SE442820B (sv) * | 1984-06-08 | 1986-02-03 | Pharmacia Ab | Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut |
| SE456346B (sv) * | 1984-07-23 | 1988-09-26 | Pharmacia Ab | Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning |
| US4582865A (en) * | 1984-12-06 | 1986-04-15 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
| SE8501022L (sv) * | 1985-03-01 | 1986-09-02 | Pharmacia Ab | Format alster och forfarande for dess framstellning |
| US4774093A (en) * | 1985-06-25 | 1988-09-27 | Fmc Corporation | Polysaccharide compositions, preparation and uses |
| EP0224987B1 (fr) * | 1985-11-29 | 1992-04-15 | Biomatrix, Inc. | Systèmes à base de l'hyaluronanne, de ses dérivés et de ses sels pour la libération de médicaments et leur procédé de fabrication |
| AU604236B2 (en) * | 1986-04-28 | 1990-12-13 | Iolab, Inc. | Intraocular dosage compositions and method of use |
| US4795741A (en) * | 1987-05-06 | 1989-01-03 | Biomatrix, Inc. | Compositions for therapeutic percutaneous embolization and the use thereof |
| EP0416250A3 (en) * | 1989-08-01 | 1991-08-28 | The Research Foundation Of State University Of New York | N-acylurea and o-acylisourea derivatives of hyaluronic acid |
-
1990
- 1990-06-25 US US07/543,163 patent/US5017229A/en not_active Expired - Lifetime
-
1991
- 1991-06-25 DK DK91914691.0T patent/DK0537292T3/da active
- 1991-06-25 JP JP51424391A patent/JP3399526B2/ja not_active Expired - Lifetime
- 1991-06-25 DE DE69125609T patent/DE69125609T2/de not_active Expired - Lifetime
- 1991-06-25 WO PCT/US1991/004543 patent/WO1992000105A1/fr active IP Right Grant
- 1991-06-25 EP EP91914691A patent/EP0537292B1/fr not_active Expired - Lifetime
- 1991-06-25 ES ES91914691T patent/ES2100954T3/es not_active Expired - Lifetime
- 1991-06-25 AT AT91914691T patent/ATE151294T1/de not_active IP Right Cessation
- 1991-06-25 AU AU83924/91A patent/AU660282B2/en not_active Expired
-
1992
- 1992-12-16 NO NO924875A patent/NO306380B1/no not_active IP Right Cessation
- 1992-12-21 FI FI925802A patent/FI103381B/fi not_active IP Right Cessation
-
1997
- 1997-05-15 GR GR970401085T patent/GR3023436T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2100954T3 (es) | 1997-07-01 |
| FI103381B1 (fi) | 1999-06-30 |
| JPH05508161A (ja) | 1993-11-18 |
| WO1992000105A1 (fr) | 1992-01-09 |
| EP0537292B1 (fr) | 1997-04-09 |
| DE69125609D1 (de) | 1997-05-15 |
| DK0537292T3 (da) | 1997-08-04 |
| FI925802A (fi) | 1992-12-21 |
| AU8392491A (en) | 1992-01-23 |
| AU660282B2 (en) | 1995-06-22 |
| EP0537292A4 (en) | 1993-07-28 |
| NO924875D0 (no) | 1992-12-16 |
| JP3399526B2 (ja) | 2003-04-21 |
| GR3023436T3 (en) | 1997-08-29 |
| NO924875L (no) | 1992-12-16 |
| US5017229A (en) | 1991-05-21 |
| ATE151294T1 (de) | 1997-04-15 |
| EP0537292A1 (fr) | 1993-04-21 |
| FI925802A0 (fi) | 1992-12-21 |
| FI103381B (fi) | 1999-06-30 |
| DE69125609T2 (de) | 1997-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO306380B1 (no) | Vannulöselig bioforlikelig gel | |
| US6030958A (en) | Water insoluble derivatives of hyaluronic acid | |
| US6174999B1 (en) | Water insoluble derivatives of polyanionic polysaccharides | |
| US6235726B1 (en) | Water insoluble derivatives of polyanionic polysaccharides | |
| US4937270A (en) | Water insoluble derivatives of hyaluronic acid | |
| US5527893A (en) | Water insoluble derivatives of polyanionic polysaccharides | |
| US6610669B1 (en) | Water insoluble derivatives of polyanionic polysaccharides | |
| US7651702B2 (en) | Crosslinking hyaluronan and chitosanic polymers | |
| US20080292664A1 (en) | Hydrogels and Hyaluronic Acid and Alpha, Beta-Polyaspartyl-Hydrazide and Their Biomedical and Pharmaceutical Uses | |
| JP4044291B2 (ja) | 水膨潤性高分子ゲルおよびその製造法 | |
| JP2670996C (fr) | ||
| Shavandi et al. | Dissolution, Extraction and Biomedical Application of Keratin: Methods and Factors Affecting the Extraction and Physicochemical Properties of Keratin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |